US Stock MarketDetailed Quotes

CRBP Corbus Pharmaceuticals

Watchlist
  • 37.2500
  • +0.2100+0.57%
Close May 1 16:00 ET
  • 37.9100
  • +0.6600+1.77%
Post 17:05 ET
391.39MMarket Cap-3612P/E (TTM)

Corbus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Corbus Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-1.79

+31.42%
Analyst Rating

Buy

Apr 30, 2024

Corbus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 100.000K--
--2022/Q10.000 / 75.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 100.000K--
--2022/Q10.000 / 75.000K--

Unlock Free Earnings Estimates

Corbus Pharmaceuticals Earnings Reports

  • Corbus Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Mar 20 17:13 ET

  • Corbus Pharmaceuticals | 10-K: Annual report

    Mar 12 17:24 ET

  • Corbus Pharmaceuticals: Q3 2023 Earnings Report

    Nov 7, 2023 16:57 ET

  • Corbus Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 17:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg